David A. Vargas
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0002-6997-911XPilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Biocatalytic strategy for the construction of sp3-rich polycyclic compounds from directed evolution and computational modelling”.
Xinkun Ren, Arkajyoti Sengupta, Ledong Zhu, Satyajit Roy, Marc Garcia‐Borràs +3 more
J. de Vries, Jimmy J.L.L. Akkermans, Yassene Mohammed, Rayman T.N. Tjokrodirijo, Arnoud H. de Ru +11 more
J.P. Bacik, Eric J. Moore, Zhuofan Shen, Ellen M. Irving, David A. Vargas +4 more
David A. Vargas, Rudi Fasan, Mary G. Siriboe
David A. Vargas, Pengchen Ma, Arkajyoti Sengupta, Ledong Zhu, K. N. Houk +2 more